Clinical Trial Update: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effectiveness of a four-drug regimen (didanosine, stavudine, nevirapine, and MKC-442) in HIV-infected patients who had n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MKC-442 (MKC-442)
• Videx (didanosine)
• Viramune (Nevirapine)
• Zerit (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 2 | Status: TERMINATED